{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:32:19Z","timestamp":1783099939032,"version":"3.54.6"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T00:00:00Z","timestamp":1581379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2019.01022","type":"journal-article","created":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T06:06:11Z","timestamp":1581401171000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Pregabalin Abuse in Combination With Other Drugs: Monitoring Among Methadone Patients"],"prefix":"10.3389","volume":"10","author":[{"given":"Massimo","family":"Lancia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Gambelunghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Gili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Bacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyriaki","family":"Aroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Gambelunghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,11]]},"reference":[{"key":"B1","unstructured":"NSDUH Data review prescription drug use and misuse in the United States: results from the 2015 National survey on drug use and health HughesA WilliamsMR LipariRN BoseJ CopelloEAP Natl Surv Drug Use Heal2016"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1159\/000337028","article-title":"Misuse of medicines in the European Union: a systematic review of the literature","volume":"18","author":"Casati","year":"2012","journal-title":"Eur Addict Res"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyz007","article-title":"An insight into Z-Drug abuse and dependence: an examination of reports to the European medicines agency database of suspected adverse drug reactions","volume":"22","author":"Schifano","year":"2019","journal-title":"Int J Neuropsychopharmacol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2165\/11587640-000000000-00000","article-title":"Patterns of methylphenidate use and assessment of its abuse and diversion in two french administrative areas using a proxy of deviant behaviour determined from a reimbursement database","volume":"25","author":"Frauger","year":"2011","journal-title":"CNS Drugs"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1268417","article-title":"Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany","volume":"44","author":"Franke","year":"2011","journal-title":"Pharmacopsychiatry"},{"key":"B6","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s12888-016-0909-3","article-title":"Nonmedical use of prescription drugs in the European Union","volume":"16","author":"Novak","year":"2016","journal-title":"BMC Psychiatry"},{"key":"B7","unstructured":"Critical Review Report: Pregabalin Expert Committee on Drug Dependence Forty-first Meeting 2018"},{"key":"B8","unstructured":"Clinical use of pregabalin in the management of central neuropathic pain FinnerupNB JensenTS 10.2147\/ndt.s1715Neuropsychiatr Dis Treat32007"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.18203\/2319-2003.ijbcp20150359","article-title":"A review of the drug pregabalin","volume":"4","author":"Manjushree","year":"2015","journal-title":"Int J Basic Clin Pharmacol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2174\/13816128113199990425","article-title":"The potential of pregabalin in neurology, psychiatry and addiction: a qualitative overview","volume":"19","author":"Martinotti","year":"2013","journal-title":"Curr Pharm Des"},{"key":"B11","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/s0959-4388(03)00066-7","article-title":"Auxiliary subunits: essential components of the voltage-gated calcium channel complex","volume":"13","author":"Arikkath","year":"2003","journal-title":"Curr Opin Neurobiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.5812\/aapm.7743","article-title":"Gabapentinoids: gabapentin and pregabalin for postoperative pain management","volume":"2","author":"Imani","year":"2012","journal-title":"Anesthesiol Pain Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.5414\/CP202118","article-title":"Pregabalin\u00e2\u20ac\u2122s abuse potential: a mini review focusing on the pharmacological profile","volume":"52","author":"Papazisis","year":"2014","journal-title":"Int J Clin Pharmacol Ther"},{"key":"B14","article-title":"Potential for pregabalin abuse or diversion after past drug-seeking behavior","volume":"110","author":"Filipetto","year":"2010","journal-title":"J Am Osteopath Assoc"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2010.09091269","article-title":"Pregabalin abuse, dependence, and withdrawal: a case report","volume":"167","author":"Grosshans","year":"2010","journal-title":"Am J Psychiatry"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2006.02.004","article-title":"Pregabalin-associated acute psychosis and epileptiform EEG-changes","volume":"15","author":"Olaizola","year":"2006","journal-title":"Seizure"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.5350\/KPB-BCP201121110","article-title":"Pregabalin abuse: a case report\/pregabalin k\u00f6t\u00fcye kullan\u0131m\u0131: bir olgu sunumu","volume":"21","author":"Yargic","year":"2011","journal-title":"Klin Psikofarmakol B\u00fclteni\/Bull Clin Psychopharmacol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0b013e3182872718","article-title":"Concerns about pregabalin","volume":"7","author":"Gahr","year":"2013","journal-title":"J Addict Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2515\/therapie\/2015010","article-title":"Drug abuse monitoring: which pharmacoepidemiological resources at the European level?","volume":"70","author":"Lapeyre-Mestre","year":"2015","journal-title":"Therapie"},{"key":"B20","article-title":"Annual report 2010-the State of the drugs problem in Europe","year":"","journal-title":"State Drugs Probl Eur"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1159\/000321079","article-title":"Is there a recreational misuse potential for pregabalin analysis of anecdotal online reports in comparison with related gabapentin and clonazepam data","volume":"80","author":"Schifano","year":"2011","journal-title":"Psychother Psychosom"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1177\/1060028015620800","article-title":"Gabapentin","volume":"50","author":"Mersfelder","year":"2016","journal-title":"Ann Pharmacother"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/add.13324","article-title":"Gabapentin misuse, abuse and diversion: a systematic review","volume":"111","author":"Smith","year":"2016","journal-title":"Addiction"},{"key":"B24","doi-asserted-by":"crossref","DOI":"10.4140\/TCP.n.2019.490","article-title":"Gabapentin: change is in the wind","volume":"34","author":"McPherson","year":"2019","journal-title":"Sr Care Pharm"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-014-0164-4","article-title":"Misuse and abuse of pregabalin and gabapentin: cause for concern?","volume":"28","author":"Schifano","year":"2014","journal-title":"CNS Drugs"},{"key":"B26","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.therap.2017.01.010","article-title":"Dispositif pharmaco\u00e9pid\u00e9miologique de surveillance des substances psychoactives: int\u00e9r\u00eats du programme national OPPIDUM du R\u00e9seau fran\u00e7ais d'addictovigilance","volume":"72","author":"Frauger","year":"2017","journal-title":"Therapies"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-016-0359-y","article-title":"A decade of gabapentinoid misuse: an analysis of the European medicines agency's \u2018suspected adverse drug reactions' database","volume":"30","author":"Chiappini","year":"2016","journal-title":"CNS Drugs"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/cns.13115","article-title":"Pregabalin: a range of misuse-related unanswered questions","volume":"25","author":"Schifano","year":"2019","journal-title":"CNS Neurosci Ther"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2017.08.430","article-title":"How addictive are gabapentin and pregabalin? A systematic review","volume":"27","author":"Bonnet","year":"2017","journal-title":"Eur Neuropsychopharmacol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1159\/000355268","article-title":"Gabapentinoid abuse in order to potentiate the effect of methadone: a survey among substance misusers","volume":"20","author":"Baird","year":"2014","journal-title":"Eur Addict Res"},{"key":"B31","article-title":"Gabapentinoid Use Disorder: Update for Clinicians","volume":"4","author":"Pergolizzi","year":"2018","journal-title":"EC Anaesth"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.24869\/psyd.2018.142","article-title":"On the addictive power of gabapentinoids: a mini-review","volume":"30","author":"Bonnet","year":"2018","journal-title":"Psychiatr Danub"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-013-1578-5","article-title":"Pregabalin abuse among opiate addicted patients","volume":"69","author":"Grosshans","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"B34","unstructured":"Schedules of controlled substances: placement of pregabalin into schedule V. Final ruleFed Regist702005"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.12159","article-title":"Prescription medication misuse among opioid dependent patients seeking inpatient detoxification","volume":"24","author":"Wilens","year":"2015","journal-title":"Am J Addict"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s11126-016-9421-7","article-title":"Abuse of gabapentin is associated with opioid addiction","volume":"87","author":"Bastiaens","year":"2016","journal-title":"Psychiatr Q"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-017-0467-3","article-title":"Pregabalin use among users of illicit drugs: a cross-sectional survey in Southern Germany","volume":"31","author":"Snellgrove","year":"2017","journal-title":"CNS Drugs"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/dta.2347","article-title":"GC-MS\/MS detects potential pregabalin abuse in susceptible subjects' hair","volume":"10","author":"Ianni","year":"2018","journal-title":"Drug Test Anal"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000327","article-title":"Cannabis use surveillance by sweat analysis","volume":"38","author":"Gambelunghe","year":"2016","journal-title":"Ther Drug Monit"},{"key":"B40","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/S13643-016-0317-2","article-title":"Association between cannabis use and treatment outcomes in patients receiving methadone maintenance treatment: a systematic review protocol","volume":"5","author":"Zielinski","year":"2016","journal-title":"Syst Rev"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.2013.12044.x","article-title":"Impact of cannabis use during stabilization on methadone maintenance treatment","volume":"22","author":"Scavone","year":"2013","journal-title":"Am J Addict"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2013.05.008","article-title":"Treatment or \u201chigh\u201d: benzodiazepine use in patients on injectable heroin or oral opioids","volume":"38","author":"Vogel","year":"2013","journal-title":"Addict Behav"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2014.06.030","article-title":"Pregabalin serum levels in apprehended drivers","volume":"243","author":"Kriikku","year":"2014","journal-title":"Forensic Sci Int"},{"key":"B44","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/dta.1818","article-title":"Patterns of drug abuse among drug users with regular and irregular attendance for treatment as detected by comprehensive UHPLC-HR-TOF-MS","volume":"8","author":"Sundstr\u00f6m","year":"2016","journal-title":"Drug Test Anal"},{"key":"B45","article-title":"Pregabalin Abuse amongst Opioid Substitution Treatment Patients","volume":"108","author":"McNamara","year":"2015","journal-title":"Ir Med J"},{"key":"B46","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.drugalcdep.2018.04.025","article-title":"Pregabalin misuse in methadone maintenance treatment patients in Israel: Prevalence and risk factors","volume":"189","author":"Sason","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"B47","first-page":"28","article-title":"Needs assessment and treatment compliance at state opioid substitution treatment programes in Georgia","author":"Piralishvili","year":"2013","journal-title":"Georgian Med News"},{"key":"B48","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/hup.2512","article-title":"New psychoactive substances as part of polydrug abuse within opioid maintenance treatment revealed by comprehensive high-resolution mass spectrometric urine drug screening","volume":"31","author":"Heikman","year":"2016","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/add.13843","article-title":"Risk to heroin users of polydrug use of pregabalin or gabapentin","volume":"112","author":"Lyndon","year":"2017","journal-title":"Addiction"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.forsciint.2014.04.028","article-title":"Profiles of pregabalin and gabapentin abuse by postmortem toxicology","volume":"241","author":"H\u00e4kkinen","year":"2014","journal-title":"Forensic Sci Int"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0700-x","article-title":"Abuse and misuse of pregabalin and gabapentin","volume":"77","author":"Evoy","year":"2017","journal-title":"Drugs"},{"key":"B52","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s40263-015-0303-6","article-title":"Abuse potential of pregabalin","volume":"30","author":"Schjerning","year":"2016","journal-title":"CNS Drugs"},{"key":"B53","doi-asserted-by":"publisher","first-page":"k4978","DOI":"10.1136\/bmj.k4978","article-title":"Need for international classification of gabapentin as a controlled substance","volume":"363","author":"Peckham","year":"2018","journal-title":"BMJ"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/jat.1054","article-title":"Hair analysis by GC\/MS\/MS to verify abuse of drugs","volume":"25","author":"Gambelunghe","year":"2005","journal-title":"J Appl Toxicol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cca.2006.02.019","article-title":"State of the art in hair analysis for detection of drug and alcohol abuse","volume":"370","author":"Pragst","year":"2006","journal-title":"Clin Chim Acta"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/26.7.479","article-title":"Segmental ion spray LC-MS-MS analysis of benzodiazepines in hair of psychiatric patients","volume":"26","author":"Kronstrand","year":"2002","journal-title":"J Anal Toxicol"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2019.01022\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T06:24:33Z","timestamp":1665815073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2019.01022\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,11]]},"references-count":56,"alternative-id":["10.3389\/fpsyt.2019.01022"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2019.01022","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,11]]},"article-number":"1022"}}